Clinical

Houston Methodist Hospital Announces First Implant of New FDA-Approved Stent Graft to Treat Peripheral Arterial Disease

Vascular Surgery team use balloon-expandable stent graft designed to treat disease in iliac arteries


Houston-Methodist-copy1
By George Kovacik | February 10, 2017

Houston Methodist Hospital is the first institution in the United States to implant a new FDA-approved device that successfully restored blood flow to a patient’s clogged iliac arteries, the three arteries that run from the end of the aorta down to the pelvis and legs.

Jean Bismuth, M.D., a vascular surgeon with the Houston Methodist DeBakey Heart & Vascular Center, was the primary investigator for the VBX FLEX IDE clinical study and the first to implant the new GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis (VBX Stent Graft).

“Hardened blockages had narrowed the patient’s right iliac artery by 70 percent and restricted blood flow to the legs, causing the patient to be in severe pain even at rest,” Bismuth said. “Such calcification can also lead to leg cramping, sexual dysfunction, difficulty walking, and even gangrene and amputation. The condition was severely hampering this patient’s quality of life.”

Peripheral arterial disease (PAD) occurs when the vessels that carry blood to the legs, arms, stomach or kidneys become narrow, restricting blood flow to those areas. According to the Centers for Disease Control (CDC) more than 8 million people in the United States have PAD. Risk factors for peripheral arterial disease include smoking, diabetes, high blood pressure, and other factors.

Bismuth says that because the iliac artery tends to be more highly calcified in comparison to other vessels, stents require greater radial strength and flexibility to restore blood flow to a patient’s legs.

“The construct of this device is much different than the other stents used to open up iliac arteries,” Bismuth said. “Most stents are one unit, however, this stent is like a bunch of independent stents within the one stent. It conforms better, and it’s the missing link of what we needed to treat this type of condition.”

Bismuth says there were no recorded incidences of device dislodgement, failures in stent integrity, or device-related serious adverse events during the nine-month trial.

“This first procedure went extremely well and I think the patient’s quality of life is going to dramatically improve.” Bismuth said. “As vascular surgeons we are always looking for new ways to help our patients through a minimally-invasive approach and I believe we have found it with this new stent.”

Tags | Clinical



Social Posts

profile_image

BCMHouston

@bcmhouston

Baylor College of Medicine will be closed Monday, May 28 in observance of Memorial Day. https://t.co/6CNQMhyJ92

2 hours ago
profile_image

Baylor College of Medicine

BaylorCollegeOfMedicine

Baylor College of Medicine will be closed Monday, May 28 in observance of Memorial Day.

2 hours ago
profile_image

TAMU Health Sciences

@TAMHSC

#TAMHSC researchers are working to solve #diabetes-related blindness: https://t.co/D1Pi8CaD0H #Health

2 hours ago
profile_image

MD Anderson Cancer Center

@MDAndersonNews

#Melanoma survivor explains how #immunotherapy #clinicaltrial and @DrSapnaPatel gave her hope. #CancerMoonShot #endcancer https://t.co/gxr9MaYsHi

2 hours ago
profile_image

MD Anderson Cancer Center

MDAnderson

Leticia Rousseve found comfort whenever she verbalized her frustrations and feelings to others who understood what she was going through as a caregiver for her husband, James, during his soft tissue sarcoma treatment. “This taught me an important lesson that I now share with others going through cancer: you are not alone.” Now, she pays it forward by volunteering with myCancerConnection, MD Anderson’s one-on-one cancer support community of patients, survivors and caregivers who have been there. #endcancer

3 hours ago
profile_image

Veterans Affairs

@DeptVetAffairs

At sprawling VA hospital in southern Dallas, a righteous battle to keep the promise to care for America's Veterans https://t.co/yBX7Jqyn6X via @dallasnews

3 hours ago
profile_image

Houston Methodist

@MethodistHosp

6.1, 11:30 a.m.-1 p.m.: Join @MethodistHosp Cancer Center at St. John for a celebration and luncheon as we honor those living with a history of cancer. Register today: https://t.co/epZbgu9fA0 https://t.co/FLv19JSQs0

3 hours ago
profile_image

Veterans Affairs

@DeptVetAffairs

Today’s #VeteranOfTheDay is @USArmy Veteran M. Ross Kirk. https://t.co/Z1oqPWmWig

3 hours ago
profile_image

U.S. Department of Veterans Affairs

VeteransAffairs

Today’s #VeteranOfTheDay is Army Veteran M. Ross Kirk. Ross served for 28 years and retired in 1988. He attained the rank of lieutenant colonel. Ross served two tours in Vietnam with the 4/39th Infantry Battalion, the 9th Infantry Division and the 5th Special Forces Group with the Chaplain Corps. He was also a member of the 101st Airborne Division, the 18th Airborne Corps 1st Division, and the Green Beret Parachute Demonstration Team. He wore the Green Beret on active duty for nine years and is nicknamed the “Leapin’ Deacon” due to his 225 military jumps, including 50 HALO (high altitude, low opening) jumps and 450 sport parachute jumps. Ross’ positions in the Army included Command Chaplain for the Special Operations Command (Airborne) and Senior Chaplain of the Combined Peacekeeping Forces in the liberation of Grenada. He retired at Fort Riley, Kansas in 1988 and has lived with his wife Judy in Wakefield, Kansas for 27 years. They have four children, eight grandchildren and one great-grandchild. Ross was awarded four Bronze Stars, five Air Medals, the Meritorious Service Medal with three Oak Leaf Clusters, the Joint Service Commendation Medal, the Army Commendation Medal with two Oak Leaf Clusters, the Army Achievement Medal and the Good Conduct Medal. He also earned the Ranger Tab, the Special Forces Tab and Master Parachutist and Air Assault Badges. Thank you for your service, Ross!

4 hours ago
profile_image

Veterans Affairs

@DeptVetAffairs

New @USDOT program provides free pilot training for Veterans https://t.co/z6mIJVPMlU via @Militarydotcom

4 hours ago
profile_image

BCMHouston

@bcmhouston

New research funded by Department of Defense grants will look into why some women with estrogen receptor-positive breast cancer develop resistance to endocrine therapies. https://t.co/TMhNyXWZ8Y

5 hours ago
profile_image

Baylor College of Medicine

BaylorCollegeOfMedicine

Congratulations to M.D/Ph.D. student Muhammad Saad Shamim on becoming a 2018 fellow of the Paul & Daisy Soros Fellowships for New Americans program.

5 hours ago
profile_image

MD Anderson Cancer Center

@MDAndersonNews

#Chemobrain is real. Learn more about this common #cancer treatment side effect: https://t.co/86Kcj2AzFy #endcancer https://t.co/iH7IP2dIUv

5 hours ago
profile_image

MD Anderson Cancer Center

@MDAndersonNews

What you need to know about #prostatecancer screening: https://t.co/Sbt5pA5B0J @oncolognews #endcancer

7 hours ago
profile_image

BCMHouston

@bcmhouston

Dr. Elizabeth McIngvale talks about her journey with obsessive compulsive disorder. https://t.co/SxpIBc1gyA #MentalHealthAwarenessMonth

9 hours ago